Global Aflibercept Biosimilars Competitive Landscape Professional Research Report 2024

Research Summary

Aflibercept biosimilars are biologic medical products highly similar to the original aflibercept (marketed as Eylea), which is an anti-VEGF (vascular endothelial growth factor) therapy used primarily to treat various retinal diseases, including age-related macular degeneration (AMD) and diabetic retinopathy. These biosimilars undergo rigorous testing to demonstrate their equivalence in terms of safety, efficacy, and quality to the reference product, providing more cost-effective treatment options while maintaining therapeutic benefits for patients suffering from serious eye conditions that can lead to vision loss.

According to DIResearch's in-depth investigation and research, the global Aflibercept Biosimilars market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Aflibercept Biosimilars include Bayer, Roche, Regeneron, Sanofi, Novartis, Sartorius, Amgen, Samsung Bioepis, Mylan, Formycon, Coherus BioSciences, Cadila Pharmaceuticals, Hetero, Biocon, Gene Techno Science, Qilu Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Aflibercept Biosimilars. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Aflibercept Biosimilars market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Aflibercept Biosimilars market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Aflibercept Biosimilars industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Aflibercept Biosimilars Include:

Bayer

Roche

Regeneron

Sanofi

Novartis

Sartorius

Amgen

Samsung Bioepis

Mylan

Formycon

Coherus BioSciences

Cadila Pharmaceuticals

Hetero

Biocon

Gene Techno Science

Qilu Pharmaceutical

Aflibercept Biosimilars Product Segment Include:

Intravitreal Injection

Intravenous Injection

Aflibercept Biosimilars Product Application Include:

Wet Macular Degeneration

Metastatic Colorectal Cancer

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Aflibercept Biosimilars Industry PESTEL Analysis

Chapter 3: Global Aflibercept Biosimilars Industry Porter's Five Forces Analysis

Chapter 4: Global Aflibercept Biosimilars Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Aflibercept Biosimilars Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Aflibercept Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Aflibercept Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Aflibercept Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Aflibercept Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Aflibercept Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Aflibercept Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Aflibercept Biosimilars Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Aflibercept Biosimilars Market Overview

1.1 Product Definition and Statistical Scope

1.2 Aflibercept Biosimilars Product by Type

1.2.1 Global Aflibercept Biosimilars Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Intravitreal Injection

1.2.3 Intravenous Injection

1.3 Aflibercept Biosimilars Product by Application

1.3.1 Global Aflibercept Biosimilars Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Wet Macular Degeneration

1.3.3 Metastatic Colorectal Cancer

1.4 Global Aflibercept Biosimilars Market Revenue and Sales Analysis

1.4.1 Global Aflibercept Biosimilars Market Size Analysis (2019-2030)

1.4.2 Global Aflibercept Biosimilars Market Sales Analysis (2019-2030)

1.4.3 Global Aflibercept Biosimilars Market Sales Price Trend Analysis (2019-2030)

1.5 Aflibercept Biosimilars Market Development Status and Trends

1.5.1 Aflibercept Biosimilars Industry Development Status Analysis

1.5.2 Aflibercept Biosimilars Industry Development Trends Analysis

2 Aflibercept Biosimilars Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Aflibercept Biosimilars Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Aflibercept Biosimilars Market Analysis by Regions

4.1 Aflibercept Biosimilars Overall Market: 2023 VS 2024 VS 2030

4.2 Global Aflibercept Biosimilars Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Aflibercept Biosimilars Revenue and Market Share by Region (2019-2024)

4.2.2 Global Aflibercept Biosimilars Revenue Forecast by Region (2025-2030)

4.3 Global Aflibercept Biosimilars Sales and Forecast Analysis (2019-2030)

4.3.1 Global Aflibercept Biosimilars Sales and Market Share by Region (2019-2024)

4.3.2 Global Aflibercept Biosimilars Sales Forecast by Region (2025-2030)

4.4 Global Aflibercept Biosimilars Sales Price Trend Analysis (2019-2030)

5 Global Aflibercept Biosimilars Market Size by Type and Application

5.1 Global Aflibercept Biosimilars Market Size by Type

5.1.1 Global Aflibercept Biosimilars Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Aflibercept Biosimilars Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Aflibercept Biosimilars Market Size by Application

5.2.1 Global Aflibercept Biosimilars Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Aflibercept Biosimilars Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Aflibercept Biosimilars Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Aflibercept Biosimilars Market Size by Type

6.3.1 North America Aflibercept Biosimilars Sales by Type (2019-2030)

6.3.2 North America Aflibercept Biosimilars Revenue by Type (2019-2030)

6.4 North America Aflibercept Biosimilars Market Size by Application

6.4.1 North America Aflibercept Biosimilars Sales by Application (2019-2030)

6.4.2 North America Aflibercept Biosimilars Revenue by Application (2019-2030)

6.5 North America Aflibercept Biosimilars Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Aflibercept Biosimilars Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Aflibercept Biosimilars Market Size by Type

7.3.1 Europe Aflibercept Biosimilars Sales by Type (2019-2030)

7.3.2 Europe Aflibercept Biosimilars Revenue by Type (2019-2030)

7.4 Europe Aflibercept Biosimilars Market Size by Application

7.4.1 Europe Aflibercept Biosimilars Sales by Application (2019-2030)

7.4.2 ? Europe Aflibercept Biosimilars Revenue by Application (2019-2030)

7.5 Europe Aflibercept Biosimilars Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Aflibercept Biosimilars Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Aflibercept Biosimilars Market Size by Type

8.3.1 China Aflibercept Biosimilars Sales by Type (2019-2030)

8.3.2 China Aflibercept Biosimilars Revenue by Type (2019-2030)

8.4 China Aflibercept Biosimilars Market Size by Application

8.4.1 China Aflibercept Biosimilars Sales by Application (2019-2030)

8.4.2 China Aflibercept Biosimilars Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Aflibercept Biosimilars Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Aflibercept Biosimilars Market Size by Type

9.3.1 APAC (excl. China) Aflibercept Biosimilars Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Aflibercept Biosimilars Revenue by Type (2019-2030)

9.4 APAC (excl. China) Aflibercept Biosimilars Market Size by Application

9.4.1 APAC (excl. China) Aflibercept Biosimilars Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Aflibercept Biosimilars Revenue by Application (2019-2030)

9.5 APAC (excl. China) Aflibercept Biosimilars Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Aflibercept Biosimilars Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Aflibercept Biosimilars Market Size by Type

10.3.1 Latin America Aflibercept Biosimilars Sales by Type (2019-2030)

10.3.2 Latin America Aflibercept Biosimilars Revenue by Type (2019-2030)

10.4 Latin America Aflibercept Biosimilars Market Size by Application

10.4.1 Latin America Aflibercept Biosimilars Sales by Application (2019-2030)

10.4.2 Latin America Aflibercept Biosimilars Revenue by Application (2019-2030)

10.5 Latin America Aflibercept Biosimilars Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Aflibercept Biosimilars Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Aflibercept Biosimilars Market Size by Type

11.3.1 Middle East & Africa Aflibercept Biosimilars Sales by Type (2019-2030)

11.3.2 Middle East & Africa Aflibercept Biosimilars Revenue by Type (2019-2030)

11.4 Middle East & Africa Aflibercept Biosimilars Market Size by Application

11.4.1 Middle East & Africa Aflibercept Biosimilars Sales by Application (2019-2030)

11.4.2 Middle East & Africa Aflibercept Biosimilars Revenue by Application (2019-2030)

11.5 Middle East & Africa Aflibercept Biosimilars Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Aflibercept Biosimilars Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Aflibercept Biosimilars Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Aflibercept Biosimilars Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Aflibercept Biosimilars Average Sales Price by Manufacturers (2020-2024)

12.2 Aflibercept Biosimilars Competitive Landscape Analysis and Market Dynamic

12.2.1 Aflibercept Biosimilars Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Bayer

13.1.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Bayer Aflibercept Biosimilars Product Portfolio

13.1.3 Bayer Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Roche

13.2.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Roche Aflibercept Biosimilars Product Portfolio

13.2.3 Roche Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Regeneron

13.3.1 Regeneron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Regeneron Aflibercept Biosimilars Product Portfolio

13.3.3 Regeneron Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Sanofi

13.4.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Sanofi Aflibercept Biosimilars Product Portfolio

13.4.3 Sanofi Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Novartis

13.5.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Novartis Aflibercept Biosimilars Product Portfolio

13.5.3 Novartis Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Sartorius

13.6.1 Sartorius Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Sartorius Aflibercept Biosimilars Product Portfolio

13.6.3 Sartorius Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Amgen

13.7.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Amgen Aflibercept Biosimilars Product Portfolio

13.7.3 Amgen Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Samsung Bioepis

13.8.1 Samsung Bioepis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Samsung Bioepis Aflibercept Biosimilars Product Portfolio

13.8.3 Samsung Bioepis Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Mylan

13.9.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Mylan Aflibercept Biosimilars Product Portfolio

13.9.3 Mylan Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.10 Formycon

13.10.1 Formycon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Formycon Aflibercept Biosimilars Product Portfolio

13.10.3 Formycon Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.11 Coherus BioSciences

13.11.1 Coherus BioSciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Coherus BioSciences Aflibercept Biosimilars Product Portfolio

13.11.3 Coherus BioSciences Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.12 Cadila Pharmaceuticals

13.12.1 Cadila Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Cadila Pharmaceuticals Aflibercept Biosimilars Product Portfolio

13.12.3 Cadila Pharmaceuticals Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.13 Hetero

13.13.1 Hetero Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Hetero Aflibercept Biosimilars Product Portfolio

13.13.3 Hetero Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.14 Biocon

13.14.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Biocon Aflibercept Biosimilars Product Portfolio

13.14.3 Biocon Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.15 Gene Techno Science

13.15.1 Gene Techno Science Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Gene Techno Science Aflibercept Biosimilars Product Portfolio

13.15.3 Gene Techno Science Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.16 Qilu Pharmaceutical

13.16.1 Qilu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Qilu Pharmaceutical Aflibercept Biosimilars Product Portfolio

13.16.3 Qilu Pharmaceutical Aflibercept Biosimilars Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Aflibercept Biosimilars Industry Chain Analysis

14.2 Aflibercept Biosimilars Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Aflibercept Biosimilars Typical Downstream Customers

14.4 Aflibercept Biosimilars Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support